The following reports are published and available for immediate shipment.

 

Please contact Al Doig at adoig@healthtech.com to suggest topics to be updated or new topics to be covered in the area of pharmaceutical drug discovery and development.

---

2002/03/04 Reports

The following reports are available for purchase in PDF format only for $1,500.00.
For a table of contents, please contact Rose LaRaia at rlaraia@healthtech.com.

Successful Pharmacogenomics Business Models

Molecular Diagnostics: Technological Advances Fueling Market Expansion

Post-Genomic Target Validation: Next Generation Approaches and Tools for Optimizing Target Selection

Cancer Genomics: Revolutionizing Treatment and Reshaping Markets through Targeted Therapies

Kinases: From Targets to Therapeutics

GPCRs: Mining the Richest Vein in Drug Discovery

Advances in Lead Optimization Accelerating Drug Discovery and Development

Life Sciences Informatics: From Data to Drugs

Proteomics Survey Report 2003 

Targeting RNA in Drug Development: Emerging Tools and Therapeutics

Prospects for the Commercialization of Human Monoclonal Antibodies

High-Content Screening: Parallel Analysis Fuels Accelerated Discovery and Development

Outlook for DNA Microarrays: Emerging Applications and Insight on Optimizing Microarray Studies

Predictive Pharmacogenomics: Revolutionizing Health Care

Toxicogenomics and Related Approaches: The Promise of Safer, Smarter Drug Development

Biochemical Pathway and Systems Analysis for Target Identification and Validation